Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre

Pukhraj Rishi; Ekta Rishi; Muna Bhende; Vishvesh Agarwal; Chinmayi H Vyas; Meenakshi Valiveti; Pramod Bhende; Chetan Rao; Pradeep Susvar; Parveen Sen; Rajiv Raman; Vikas Khetan; Vinata Murali; Dhanashree Ratra; Tarun Sharma

doi:10.1136/bjophthalmol-2015-307802

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse by collection

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Clinical science

Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Rishi P, Rishi E, Bhende M, et al

Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre

British Journal of Ophthalmology 2016;100:1337-1340.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password